| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.082 | 0.2 |